Metrohealth Ventures LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as MHS Care-Innovation LLC (to 2023)
2
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 21, 2027The maintenance fee for Compositions and Methods for Treating Fatty Tissue Buildup (US 10,538,586) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
- 1 fee due Aug 4, 2027The maintenance fee for Compositions and Methods for Treating Obesity and Hyperphagia (US 10,548,951) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,625,863 | Treatment of patients with dysfunctional cardiac sodium channels In force · USPTO record | In force | USPTO record | |
| US 8,844,530 | Combination lung ventilation and mucus clearance apparatus and method In force · USPTO record | In force | USPTO record | |
| US 8,651,107 | Manual lung ventilation device In force · USPTO record | In force | USPTO record | |
| US 10,814,082 | Combination Respiratory Therapy Device, System and Method In force · High confidence | In force | High confidence | |
| US 9,771,422 | Compositions and Methods for Treating Fatty Tissue Buildup In force · High confidence | In force | High confidence | |
| US 11,066,467 | Compositions and methods for treating ischemic heart disease In force · USPTO record | In force | USPTO record | |
| US 11,400,135 | Compositions and Methods for Treating Obesity and Hyperphagia In force · Low confidence | In force | Low confidence | |
| US 12,508,299 | Compositions and Methods for Treating Obesity and Hyperphagia In force · Low confidence | In force | Low confidence | |
| US 10,538,586 | Compositions and Methods for Treating Fatty Tissue Buildup In force · High confidence | In force | High confidence | |
| US 10,548,951 | Compositions and Methods for Treating Obesity and Hyperphagia In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 13: 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 no status recorded